You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

aGVHD

Showing 1 - 25 of 437
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT Trial (CD25

Not yet recruiting
  • The Effecacy and Safety of Humanized CD25 Antibody in aGVHD Prophylaxis Among Elderly Patients After HID-HSCT
  • CD25 prophylaxis
  • (no location specified)
Jun 20, 2023

GVHD, Acute Stem Cell Transplant Complications Trial in Chendu (Ruxolitinib)

Not yet recruiting
  • GVHD
  • Acute Stem Cell Transplant Complications
  • Chendu, Sichuan, China
    West China Hospital, Sichuan University
Oct 3, 2023

The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA Trial (Ruxolitinib 5 MG BID Oral Tablet)

Not yet recruiting
  • The Prophylactic Value of Ruxolitinib for aGVHD in HSCT Recipients of AA
  • Ruxolitinib 5 MG BID Oral Tablet
  • (no location specified)
Jun 13, 2023

aGVHD, cGVHD Trial in Beijing (Rabbit ATG)

Recruiting
  • aGVHD
  • cGVHD
  • Rabbit ATG
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Feb 21, 2022

GVHD,Acute Trial (OSSM-001)

Withdrawn
  • GVHD,Acute
  • OSSM-001
  • (no location specified)
Dec 21, 2022

Acute GVHD Trial (Itolizumab, Methylprednisolone)

Not yet recruiting
  • Acute Graft Versus Host Disease
  • (no location specified)
Apr 10, 2023

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

GVHD,Acute, Stem Cell Transplant Complications Trial in Chengdu (Methylprednisolone)

Recruiting
  • GVHD,Acute
  • Stem Cell Transplant Complications
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 9, 2022

Glucocorticoid-Refractory aGVHD Trial in Suzhou (TQ05105 tablets)

Recruiting
  • Glucocorticoid-Refractory aGVHD
  • TQ05105 tablets
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Aug 16, 2021

Acute-graft-versus-host Disease Trial in Minneapolis (Ruxolitinib 10 MG Oral Tablet, hCG, Corticosteroids)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • Ruxolitinib 10 MG Oral Tablet
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States

Completed
  • Steroid-refractory Acute Graft-versus-Host Disease
  • Treatment-refractory Acute Graft-versus-Host Disease
  • Neihulizumab (ALTB-168)
  • Duarte, California
  • +12 more
Jan 17, 2023

Fecal Microbiota Transplantation in Gut aGVHD Treated

Recruiting
  • Acute-graft-versus-host Disease
  • Fecal microbiota
  • Suzhou, Jiangsu, China
    中国
Mar 26, 2022

Gastro-Intestinal Acute GVHD (GI-aGVHD) Trial in Cleveland (Fecal Microbiota Transplantation (FMT))

Withdrawn
  • Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD)
  • Fecal Microbiota Transplantation (FMT)
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Jul 1, 2022

Acute Graft-versus-host Disease Trial in Duarte (GDC-8264)

Recruiting
  • Acute Graft-versus-host Disease
  • Duarte, California
    City of Hope National Medical Center
Jan 12, 2023

Grade B aGVHD, Grade C aGVHD, Grade D aGVHD Trial in United States (remestemcel-L)

Completed
Has Results
  • Grade B aGVHD
  • +2 more
  • Los Angeles, California
  • +19 more
Feb 18, 2022

GVHD, Acute Trial (CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs), Placebo,

Not yet recruiting
  • Graft Versus Host Disease, Acute
  • CYP-001 (Cymerus mesenchymoangioblast-derived mesenchymal stem cells; MCA-derived MSCs)
  • +2 more
  • (no location specified)
Dec 6, 2022

GVHD in GI Tract Trial in Graz (Fecal microbiota transplantation)

Recruiting
  • Graft Versus Host Disease in GI Tract
  • Fecal microbiota transplantation
  • Graz, Styria, Austria
    Division of Gastroenterology and Hepatology, Department of Inter
Apr 5, 2022

aGVHD, Stem Cell Transplant Complications Trial in Beijing (Ruxolitinib, Corticosteroid)

Recruiting
  • aGVHD
  • Stem Cell Transplant Complications
  • Beijing, Beijing, China
    Chinese PLA General Hospital
May 23, 2022

Acute-graft-versus-host Disease Trial (ASC930)

Not yet recruiting
  • Acute-graft-versus-host Disease
  • ASC930
  • (no location specified)
Nov 16, 2021

GVHD Trial (FMT)

Not yet recruiting
  • GVHD
  • FMT
  • (no location specified)
Oct 15, 2021

Pediatric HSCT Recipients With aGVHD: Prospective Observational

Recruiting
  • Graft Versus Host Disease, Acute
  • Hematopoietic Stem Cell Transplantation
    • Trieste, Italy
      IRCCS Burlo Garofolo
    Apr 30, 2022

    Hyperbaric Oxygen Therapy, Acute-graft-versus-host Disease Trial in Jinan (Hyperbaric oxygen therapy)

    Recruiting
    • Hyperbaric Oxygen Therapy
    • Acute-graft-versus-host Disease
    • Hyperbaric oxygen therapy
    • Jinan, Shandong, China
      Shandong Provincial Hospital
    Oct 13, 2021

    Acute GVH Disease Trial in Beijing (Methotrexate)

    Recruiting
    • Acute GVH Disease
    • Beijing, Beijing, China
      Peking University Institute of Hematology,Beijing
    Sep 14, 2021

    Acute GVHD Trial in Duarte, New York, Houston (Recombinant Human Interleukin-22 IgG2-Fc (F-652), Systemic Corticosteroids)

    Completed
    Has Results
    • Acute Graft vs Host Disease
    • Recombinant Human Interleukin-22 IgG2-Fc (F-652)
    • Systemic Corticosteroids
    • Duarte, California
    • +2 more
    Jul 1, 2021

    GVHD, GVHD, Acute-graft-versus-host Disease Trial in Canada, United States (Itolizumab, EQ001 Placebo)

    Recruiting
    • Graft Versus Host Disease
    • +4 more
    • Itolizumab
    • EQ001 Placebo
    • Duarte, California
    • +5 more
    Jul 5, 2022